Relationship between saxagliptin use and left ventricular diastolic function assessed by cardiac MRI.
Kathy C K WongHuda S IsmailKim A ConnellySubodh VermaMing-Yen NgDjeven P DevaAndrew T YanLaura Jimenez-JuanPublished in: Acta diabetologica (2023)
In T2DM patients without HF receiving saxagliptin over 6 months, there were no significant subclinical changes in LV diastolic function as assessed by CMR.
Keyphrases
- left ventricular
- ejection fraction
- aortic stenosis
- blood pressure
- hypertrophic cardiomyopathy
- end stage renal disease
- heart failure
- newly diagnosed
- cardiac resynchronization therapy
- acute myocardial infarction
- left atrial
- mitral valve
- prognostic factors
- contrast enhanced
- peritoneal dialysis
- metabolic syndrome
- type diabetes
- coronary artery disease
- acute coronary syndrome
- adipose tissue
- acute heart failure